SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-002292
Filing Date
2019-08-20
Accepted
2019-08-20 17:24:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D sc13da510959006_08202019.htm SC 13D/A 94368
  Complete submission text file 0000921895-19-002292.txt   95962
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42745 | Film No.: 191040597
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168 212-302-0699
BP Peptides, LLC (Filed by) CIK: 0001711689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A